Prednisolone tebutate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for prednisolone tebutate and what is the scope of patent protection?
Prednisolone tebutate
is the generic ingredient in two branded drugs marketed by Merck and Watson Labs, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for prednisolone tebutate.
Summary for prednisolone tebutate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Patent Applications: | 3,216 |
DailyMed Link: | prednisolone tebutate at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for prednisolone tebutate
US Patents and Regulatory Information for prednisolone tebutate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | PREDNISOLONE TEBUTATE | prednisolone tebutate | INJECTABLE;INJECTION | 083362-001 | Feb 17, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Merck | HYDELTRA-TBA | prednisolone tebutate | INJECTABLE;INJECTION | 010562-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |